Patents Assigned to Regencor, Inc.
  • Epicardial-derived paracrine factors for repairing cardiac tissue
    Patent number: 10682416
    Abstract: Provided herein, inter alia, are compositions and kits comprising epicardial-derived paracrine factors (such as, hypoglycosylated follistatin-like 1 (FSTL1)) for treating and repairing damage to cardiac tissue caused by cardiovascular disease, myocardial infarction (MI), other ischemic events, or cardiac-growth deficiency, as well as methods for using the same.
    Type: Grant
    Filed: April 8, 2016
    Date of Patent: June 16, 2020
    Assignees: Regencor, Inc., Sanford Burnham Prebys Medical Discovery Institute
    Inventors: Pilar Ruiz-Lozano, Mark Mercola, Ke Wei